Disorders of the Sex Chromosomes
Disorders of the sex chromosome (like disorders of the autosomes) can be either numerical or structural, and can be present in all cells or in a mosaic form. Clinical indications that should raise suspicions of a sex chromosome abnormality are:
- delay in onset of puberty;
- primary or secondary amenorrhea;
- infertility;
- ambiguous genitalia.
These disorders are considered very common with incidence of about 1:400–500. Phenotypes associated with sex chromosome disorders are less severe than autosomal defects and this is mainly due to X chromosome inactivation, as well as the fact that Y chromosomes have a low gene content. X chromosome inactivation is the the process by which most genes on one of the two X chromosomes in females are silenced epigenetically and randomly, and so fail to produce any product. In somatic cells in normal females (but not in normal males), one X chromosome is inactivated early in development, thus equalizing the expression of X-linked genes in the 2 sexes. Thus females are mosaic with respect to X-linked gene expression.
Klinefelter's Syndrome
Klinefelter syndrome, 47,XXY, or XXY syndrome is a condition where human males have an extra X chromosome.
Males normally have a chromosomal makeup of XY, but an affected individual with Klinefelter syndrome will have at least two X chromosomes and at least one Y chromosome.
The syndrome was named after Dr. Harry F. Klinefelter, who was an American rheumatologist and endocrinologist. Between 1941 and 1942, Klinefelter went for one year to Boston to work at the Massachusetts General Hospital. It was here, under the supervision of Fuller Albright, that the syndrome was first described in 1942.
Genetics
During stage I or II of meiosis (sex cell division) a nondisjunction can occur which retains the extra X chromosome and cause the Klinefelter syndrome.
Mammals normally have more than one X chromosome, but the genes from only one is expressed. This is due to X-inactivation. This is a natural process which can be seen in female mammals, XX. In the XXY male, a few genes located in the pseudoautosomal regions of their X chromosomes, have corresponding genes on their Y chromosomes and are capable of being expressed. These triploid genes present in cells of male, may be what is causing the symptoms for Klinefelter syndrome.
The cause of the excess X chromosome in the karyotype is nondisjunction during the first or second part of gametogenesis, or nondisjunction in an already formed zygote. Nondisjunction usually occurs when the chiasms of homologous chromosomes fail to divide correctly - either prematurely, late, or not at all[1]. However, it has been shown that a more common cause of aneuploidy is chromatid misdistribution, than whole chromosomes[2]. The inheritance of Klinefelter's syndrome has not been proven; it is assumed that the main cause is premature separation of sister chromatids in the gonads, with the same probability of aneuploidy occurring both paternally and maternally[3].
Aberrant recombination plays a significant role in the development of aneuploidy from the parental side, in most KS affected there was no recombination in the PAR region between Yp / Xp[4].In mothers, it can occur during cross-over between X chromosomes.
Another possible cause is the older age of the mother. The first mitotic divisions of the zygote control the mother's proteins and RNA - with increasing maternal age, the probability of zygote division errors increases, if they occur, aneuploidy may occur again and KS, but then mosaicism arises[5]. The influence of the father's age is not demonstrable on KS[6].
Although KS has inactivated the X chromosome similarly to women, not all genes on the X chromosome are inactivated. These genes are consequently much more expressed than in a man with a common karyotype - as a result of which the function of the testes is affected (especially the negative effect on fertility)[7].
An obvious correlation between phenotype and genotype in KS is the polymorphism in the number of CAG repeats in the androgen receptor gene. The result is modulation of androgen sensitivity - a shorter number of repeats corresponds to a higher sensitivity to androgens, in patients with KS there is a link between longer recurrence of CAG repeats and microorchidism, delayed development and infertility[8].
Some (about 10%) males have only the extra X chromosome present in some of their cells. This is described as mosaic Klinefelter syndrome, and can be described with some variant of mosaic karyotype (e. g. 46,XY/47,XXY). This means that some of the cells from an affected individual will show a normal karyotype, while other cells can show the karyotype of Klinefelter syndrome. These individuals usually show milder signs and symptoms of the condition, but this again depends on the number of cells expressing the affected trait.
Signs and Symptoms
The clinical picture
The main symptoms include[9]:
- typical eunuchoid habitus;
- intellect is not significantly impaired, learning disabilities or depressive statesmay occur more frequently; psychomotor retardation occurs only in forms of the syndrome with multiple X chromosomes[10];
- hypoplastic testes, azoospermia, infertility, small penis (especially in childhood, in adulthood it is mostly of normal size)[11], gynecomastia;
- beard growth disorder.
Body Form
The phenotype of the affected person is basically male, tall stature with elongated lower legs and forearms. The body shape, however, is more feminine (narrow shoulders, broad hips) with a lower muscle mass. One third of affected individuals show gynecomastia (abnormal development of mammary glands in male resulting in breast enlargement). The risk for male breast cancer and osteoporosis is also increased.
Fertility
One of the main symptoms of this condition is infertility that arises in the beginning of the third decade at its latest. The infertility is a result of atrophy of the seminiferous tubules. The testicles and penis of an affected man are small (< 10 mL, 2 cm), and the individual also express low libido and impotence.
As noted above, fertility is very rare in cases of Klinefelter syndrome, and it usually ceases in the beginning of the third decade when testicles are increasingly hyalinized.
IQ
The IQ can be reduced by 10–15 points. However, mental retardation is not a stable clinical feature of Klinefelter syndrome.
Other Features
- reduced hair growth in pubic region, axillary region, chest and face;
- varicose veins and leg ulcers;
- diabetes mellitus in 8% of cases;
- thyroid gland problems are common;
- depression;
- lung disease.
Diagnosis
Most common method for confirming the diagnosis is standard karyotyping. This procedure is done to see whether the patient has a presence of extra X chromosome. A positive karyotype would be 47,XXY; 48,XXXY; 49,XXXXY etc.
Prenatal testing can also be performed. Chorionic villi sampling and amniocentesis are two common methods where the fetus tissue is extracted and their DNA is isolated and genetically tested for abnormalities.
Other tests that can be performed includes; semen count; and blood tests checking hormone levels.
Frequency
Klinefelter syndrome affects worldwide every 1/500 to 1/1000 male births.
ICD-10 classification
Klinefelter's syndrome according to ICD-10:
- Q98.0 Klinefelter's syndrome ‚karyotype 47‚XXY;
- Q98.1 Klinefelter's syndrome ‚a man with more than two X chromosomes;
- Q98.2 Klinefelter's syndrome ‚man with karyotype 46‚XX;
- Q98.4 Klinefelter's syndrome NS (unspecified).
Treatment
Life expectancy is normal, yet the morbidity and mortality tends to be higher.
The genetic disorder itself is irreversible. But testosterone therapy has shown to help with gaining a more masculine appearance:
- increased body hair growth;
- increased muscle tone and mass;
- increased energy and sexual drive;
- increased mood and general self esteem;
- also show to increase cognitive concentration.
Since most affected individuals can not make a woman pregnant, assisted reproduction specialists are available for help (IVF using sperm from the donor).
Turner's Syndrome
Overview
This syndrome is typically characterized by a 45,X karyotype in females (in about 50% of cases), with the absence of one X chromosome (and therefore absence of a Barr body). The single X chromosome is of maternal origin in about 70% of cases; therefore there is loss of a sex chromosome due to paternal error. Other possible variations include:
- 46,X,i (Xq) in 15% of cases (isochromosome of X);
- 45,X or 46,XX mosaics in 15% of cases;
- 45,X or 46,X,i (Xq) mosaics in about 5%;
- other.
Its incidence is about 1:2000 (less common than Klinefelter's) and it is present in about 1.5% of all conceptions.
Patients present with the following features:
- short stature (without hormonal treatment, average height is 145cm);
- ovarian dysgenesis (streak ovary); this is the most common cause of primary amenorrhea;
- infertility;
- shield chest with widely-spaced nipples;
- webbing of the neck postnatally (cystic hygroma in fetal life; seen in ultrasound);
- low posterior hairline;
- average intelligence;
- renal and cardiovascular abnormalities (e.g. coarctation of the aorta).
There is no actual cure for this syndrome but treatments can be done to alleviate some of its symptoms, e.g. growth hormone, estrogen replacement therapy, and reproductive technologies (to get pregnant as they are infertile, donor egg cell is needed).
Triple X Syndrome (Superfemale)
This syndrome usually results from errors in maternal meiosis I (90% of cases), and its incidence is about 1:1000. Such patients have non-specific features e.g. average intelligence, normal sexual development. About 70% have serious learning problems. In 47,XXX cells, two of the X chromosomes are inactivated. Variations include:
- tetrasomy X syndrome (48,XXXX) with more serious physical and mental retardation;
- pentasomy (49,XXXXX) with severe developmental retardation.
XYY Syndrome (Supermale)
It has an incidence of about 1:1000 male live births. It may be caused by paternal non-disjunction at meiosis II (producing a YY sperm) or by a post-zygotic event. Variants of this syndrome include XXYY and XXXYY, which probably also originate from paternal non-disjunction at both meiosis I and II. Patients are usually phenotypically normal and may have the following features:
- tall stature;
- severe acne;
- average intelligence;
- antisocial behavior with increased risk of behavioral problems (3% are in prisons & mental hospitals);
- can show emotional immaturity and impulsive behavior;
- normal fertility, without risk of chromosomal aberrations in offspring;
- normal sexual development.
Links
Related articles
Bibliography
- NUSSBAUM, Robert. Genetics in Medicine : Thompson & Thompson. Seventh edition. Saunders Elsevier, 2007. ISBN 9781416030805.
- ↑ T. Strachan, A.P. Read, Human molecular genetics(3rd ed.)Garland Publishing, New York (2004)
- ↑ A.H. Handyside, M. Montag, M.C. Magli, S. Repping, J. Harper, A. Schmutzler, et al., Multiple meiotic errors caused by predivision of chromatids in women of advanced maternal age undergoing in vitro fertilisation, Eur J Hum Genet, 20 (2012), pp. 742–747
- ↑ A.S. Gabriel, A.R. Thornhill, C.S. Ottolini, A. Gordon, A.P. Brown, J. Taylor, et al., Array comparative genomic hybridisation on first polar bodies suggests that non-disjunction is not the predominant mechanism leading to aneuploidy in humans
- ↑ N.S. Thomas, T.J. Hassold, Aberrant recombination and the origin of Klinefelter syndrome, Hum Reprod Update, 9 (2003), pp. 309–317
- ↑ P. Braude, V. Bolton, S. Moore, Human gene expression first occurs between the four- and eight-cell stages of preimplantation development, Nature, 332 (1988), pp. 459–461
- ↑ K.G. Fonseka, D.K. Griffin, Is there a paternal age effect for aneuploidy? Cytogenet Genome Res, 133 (2011), pp. 280–291
- ↑ F. Tuttelmann, J. Gromoll, Novel genetic aspects of Klinefelter's syndrome, Mol Hum Reprod, 16 (2010), pp. 386–395
- ↑ M. Zitzmann, M. Depenbusch, J. Gromoll, E. Nieschlag, X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients, J Clin Endocrinol Metab, 89 (2004), pp. 6208–6217
- ↑
- ↑
- ↑